John Mancuso
8Patents
3h-index
30Co-inventors
53Inventor score
Filing activity: May 27, 2005 → Sep 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8673911B2 | Inhibitors of histone deacetylase | Chemistry; Metallurgy | 9 | Active |
| US11884675B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11608344B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11912711B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US8399452B2 | Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12428425B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 0 | Active |
| US7321046B2 | Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9193749B2 | Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.